MedinCell has launched a COVID-19 research initiative based on its experience to formulate long-acting injectable Ivermectin
6 April 2020
Our news
Bringing you the latest!
Corporate
MedinCell receives $ 6.4 million grant from Unitaid to fight Malaria
25 March 2020
MedinCell provides a portfolio update for J.P. Morgan Healthcare Conference 2020
13 January 2020
MedinCell receives $19 million grant for its mdc-WWM program
28 November 2019
MedinCell announces that mdc-CWM progresses as planned
27 September 2019
The MedinCell General Meeting votes to include the “Raison d’être” of the Company in its articles of association
10 September 2019
MedinCell receives a new grant to develop a best-in-class long-acting injectable product for HIV PrEP
5 September 2019
LAI antipsychotic using MedinCell’s technology receives FDA IND clearance to initiate clinical activities
26 August 2019